Detalhe da pesquisa
1.
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
Cell
; 185(3): 457-466.e4, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995482
2.
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.
Cell
; 185(6): 1041-1051.e6, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202566
3.
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Cell
; 184(9): 2372-2383.e9, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743213
4.
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.
Cell
; 185(7): 1259, 2022 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35364034
5.
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Cell
; 184(9): 2523, 2021 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33930298
6.
SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022.
MMWR Morb Mortal Wkly Rep
; 72(4): 100-106, 2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36701254
7.
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines.
J Infect Dis
; 225(7): 1141-1150, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34888672
8.
Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
Clin Infect Dis
; 75(1): e884-e887, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35174389
9.
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.
Clin Infect Dis
; 73(11): 2112-2115, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993265
10.
Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation.
ACS Infect Dis
; 10(2): 553-561, 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38281136
11.
Diagnostic TR-FRET assays for detection of antibodies in patient samples.
Cell Rep Methods
; 3(3): 100421, 2023 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37056371
12.
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children.
NPJ Vaccines
; 7(1): 158, 2022 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463314
13.
Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy.
Radiother Oncol
; 166: 88-91, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838892
14.
Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer.
Cancer Cell
; 40(1): 103-108.e2, 2022 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990570
15.
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting.
Cell Rep
; 38(12): 110561, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303475
16.
Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design.
Cell Rep Med
; 3(12): 100834, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423634
17.
Comprehensive antibody profiling of mRNA vaccination in children.
bioRxiv
; 2022 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35018376
18.
Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children.
Vaccines (Basel)
; 10(4)2022 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35455241
19.
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents.
EBioMedicine
; 80: 104066, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605428
20.
Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series and Additional Dose Vaccine in Patients With Predominant Antibody Deficiency.
J Allergy Clin Immunol Pract
; 10(6): 1622-1634.e4, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381395